期刊
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
卷 169, 期 -, 页码 134-143出版社
ELSEVIER
DOI: 10.1016/j.ejpb.2021.10.001
关键词
Hydrogels; Controlled release; Nebulization; PIPAC; Intraperitoneal drug delivery; Computational fluid dynamics
资金
- Research Foundation - Flanders [1S33221N, G061119N]
- Ghent University (BOF)
- European Union's Horizon 2020 research and innovation program [810685]
This study evaluated the potential of the thermosensitive hydrogel Pluronic F127 to be applied by high pressure nebulization, finding a delicate balance between controlled release properties and suitability for aerosolization. Denser hydrogels (20% and 25% w/v Pluronic F127) could sustain nanoparticle release up to 30 hours but cannot effectively be nebulized. As Pluronic F127 concentration and viscosity increased, aerosol droplet size also increased while aerosol cone angle exponentially decreased.
Peritoneal metastasis is an advanced cancer type which can be treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC). Here, chemotherapeutics are nebulized under high pressure in the intraperitoneal (IP) cavity to obtain a better biodistribution and tumor penetration. To prevent the fast leakage of chemotherapeutics from the IP cavity, however, nebulization of controlled release formulations is of interest. In this study, the potential of the thermosensitive hydrogel Pluronic F127 to be applied by high pressure nebulization is evaluated. Therefore, aerosol formation is experimentally examined by laser diffraction and theoretically simulated by computational fluid dynamics (CFD) modelling. Furthermore, Pluronic F127 hydrogels are subjected to rheological characterization after which the release of fluorescent model nanoparticles from the hydrogels is determined. A delicate equilibrium is observed between controlled release properties and suitability for aerosolization, where denser hydrogels (20% and 25% w/v Pluronic F127) are able to sustain nanoparticle release up to 30 h, but cannot effectively be nebulized and vice versa. This is demonstrated by a growing aerosol droplet size and exponentially decreasing aerosol cone angle when Pluronic F127 concentration and viscosity increase. Novel nozzle designs or alternative controlled release formulations could move intraperitoneal drug delivery by high pressure nebulization forward.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据